البحث عن طبيب

Konstantinos Leventakos, M.D., Ph.D.

  1. Oncologist

Konstantinos Leventakos, M.D., is a medical oncologist with a focus on thoracic malignancies, personalized medicine and immunotherapy. His clinical focus includes:

  • Non-small cell lung cancer
  • Small cell lung cancer
  • Mesothelioma
  • Thymic malignancies
  • Neuroendocrine tumors
  • Multidisciplinary approach to thoracic malignancies and personalized medicine
  • Integration of Artificial Intelligence (AI) for clinical trial matching

In addition to his clinical activities, Dr. Leventakos is active in research and education of medical students, residents and Oncology fellows. He publishes in many journals and speaks at many national and international meetings.

  1. Carcinoid tumor
  2. Lung cancer
  3. Mesothelioma
  4. Neuroendocrine tumor
  5. Non-small cell lung cancer
  6. Small cell lung cancer
  7. Thymic tumor
  • Lung cancer
  • Mesothelioma
  • Thymoma and thymic cancer
  • Neuroendocrine tumors of the lung
  • Individualized medicine
  • Artificial intelligence and clinical trial matching
  • Immunotherapy
  • Early Cancer Therapeutics/Phase 1 Clinical Trials
  • Palliative care and symptom control
  • Telemedicine in Oncology
  1. 2017
    Ph.D.University of Athens Medical School
  2. 2017
    FellowHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  3. 2014
    ResidencyGeorgetown University Hospital and Washington Hospital Center
  4. 2011
    ResidencyAttikon University Hospital of Athens
  5. 2009
    Post-doctoral FellowshipUniversity of Texas MD Anderson Cancer Center
  6. 2005
    MDMedical School of University of Crete, Heraklion

Certifications

  1. 2017
    HematologyAmerican Board of Internal Medicine
  2. 2017
    Medical OncologyAmerican Board of Internal Medicine
  3. 2014
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2024
    Award of Excellence for Being the Top Clinical Trial Accruing Provider in the Lung Disease GroupComprehensive Cancer Center; Lung Disease Group
  2. 2022
    Teacher of the YearMayo Clinic Rochester Hematology/Oncology Fellows
  3. 2022
    2022 IASLC Academy MemberInternational Association for the Study of Lung Cancer (IASLC)
  4. 2021
    40 Early Career Leaders in Oncology Under Age 4040 Under 40
  5. 2017
    Tow Shung Tan Humanism in Medicine Award Mayo Clinic
  6. 2017
    Travel grant to participate in 17th Annual Targeted Therapies of Lung Cancer Meeting, Santa Monica, CA, February, 2017International Association for the Study of Lung Cancer (IASLC)
  7. 2017
    Travel Grant to represent NANETS at the 14th Annual European Neuroendocrine Tumor Society (ENETS) Conference, 3/8-10 2017 in Barcelona, SpainNorth American Neuroendocrine Tumor Society (NANETS)
  8. 2016
    ASCO Ambassadorship to represent ASCO to the Workshop on Methods in Clinical Cancer Research, held in Zeist, Netherlands, June 2016ASCO Ambassadorship
  9. 2016
    Rising Star in OncologySociety of Translational Oncology
  10. 2016
    Travel Grant for the 2016 NANETS symposium in Jackson, Wyoming 9/30 – 10/1, 2016North American Neuroendocrine Tumor Society (NANETS)
  11. 2016
    Support to participate in the Workshop on Methods in Clinical Cancer Research, held in Zeist, Netherlands. AACR, ECCO, EORTC, ESMOAmerican Association for Cancer Research
  12. 2015
    Travel grant to participate in the 2015 ESMO Preceptorship on Immuno-OncologyEuropean Society of Medical Oncology
  13. 2009
    "The 2009 Kimberly Patterson Fellowship in Leukemia Research Award" for excellence in translational and clinical researchUniversity of Texas System
  14. 2005
    Scholarship for attending the ESO Oncology Course for Medical StudentsEuropean School of Oncology
  15. 2004
    Scholarship for one-month observership in St. Elizabeth’s Medical Center of Boston, Medical School of University of Crete and Tufts University School of Medicine student exchange programStudent Exchange Program

Professional memberships

  1. 2024 - present
    Research Partner Principal InvestigatorMinnesota Cancer Clinical Trials Network (MNCCTN)
  2. 2024 - present
    PresidentMinnesota Society of Clinical Oncology (MSCO)
  3. 2023 - present
    AI & I / Innovation Practice & Research ChairDepartment of Oncology Research Committee
  4. 2023 - present
    Lead PhysicianClinical Trial Matching and Feasibility Project Committee
  5. 2021
    Residency Applicant InterviewerDepartment of Internal Medicine, Mayo Clinic, Mayo Clinic Enterprise
  6. 2021 - 2023
    Board Member, Board of DirectorsMinnesota Society of Clinical Oncology (MSCO)
  7. 2020 - present
    Co-LeaderMayo Clinic, Division of Medical Oncology, Transform the Practice - Streamlined Access to Clinical Trials
  8. 2020 - present
    MemberScientific Review Committee B
  9. 2020 - present
    MemberMayo Clinic, Division of Medical Oncology, Junior Faculty Career Development Committee
  10. 2020 - present
    MemberMayo Clinic Division of Medical Oncology Education Committee
  11. 2020 - present
    MemberMayo Clinic Internal Medicine Board Review
  12. 2019 - present
    MemberMayo Clinic Cancer Center, Early Cancer Therapeutics Disease Group
  13. 2019 - present
    MemberMayo Clinic Cancer Center, Thoracic (Lung) Disease Group
  14. 2019 - present
    MemberMayo Clinic, Division of Medical Oncology, Wellness Committee
  15. 2019 - present
    MemberWatson CTM Project Management Team
  16. 2019 - present
    MemberACCRU Scientific and Administrative Review Committee (SARC)
  17. 2015 - present
    MemberAmerican Association of Cancer Research
  18. 2014 - present
    MemberEuropean Society for Medical Oncology
  19. 2014 - present
    MemberAmerican Society of Clinical Oncology
  20. 2014 - present
    MemberInternational Association of the Study of Lung Cancer

Publications